Syngene

Syngene Collaborates with Johns Hopkins University to Advance Early-Stage Drug Discovery

India/UK/US, 11 February, 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug discovery programs and platform technologies emerging from the university’s research labs. The collaboration will be delivered by Syngene SynVent™, a fully integrated drug discovery and...

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

19 January 2026 -- Bengaluru, India -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning discovery (chemistry, biology, drug metabolism and pharmacokinetics),...

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

The new facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day 18 March 2024 – Bangalore, India – At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and manufacturing organisation (CRDMO), will announce that its newly upgraded...
Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099